HIMS
HIMS & HERS HEALTH INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
HIMS & HERS HEALTH INC (HIMS) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$39.62M; the largest are Ken Griffin, Davidson Kempner, Paul Tudor Jones. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added, 1 trimmed, 2 closed. 2 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders44 also report options
Congress trades2
Price$28.70vs quarter-end-17.22%
Sectors0
This quarter's moves
Top holderNew1
Added1
Trimmed / sold3
Ken GriffinCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Davidson KempnerHold
Value $5.55M0.1% of portfolio160,0122026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Davidson Kempner | $5.55M | 0.1% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $210.37M— of portfolio6,067,8002026 Q2
Value $108.33M— of portfolio3,124,6002026 Q2
Value $35.69M— of portfolio1,029,5002026 Q2
Value $29.75M— of portfolio858,0002026 Q2
Value $17.95M— of portfolio517,7002026 Q2
Value $17.17M— of portfolio495,3002026 Q2
Value $11.78M— of portfolio339,9002026 Q2
Value $5.27M— of portfolio151,9002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $210.37M | — | — |
| Ken GriffinPUT | $108.33M | — | — |
| Steven CohenPUT | $35.69M | — | — |
| Paul Tudor JonesCALL | $29.75M | — | — |
| Izzy EnglanderPUT | $17.95M | — | — |
| Steven CohenCALL | $17.17M | — | — |
| Paul Tudor JonesPUT | $11.78M | — | — |
| Izzy EnglanderCALL | $5.27M | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.